Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018

Alethia Young Maintained (ALNY) at Buy with Increased Target to $154 on, Mar 13th, 2018

Alethia Young of Credit Suisse, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $151 to $154 on, Mar 13th, 2018.

Alethia has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $118 on, Friday, February 9th, 2018
  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $135 on, Thursday, January 25th, 2018


This is the rating of the analyst that currently disagrees with Alethia


  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $160 on, Friday, February 9th, 2018